D-lactic acid inhibits Candida albicans associated with vulvovaginal candidiasis: in vitro and in vivo effects and underlying mechanisms
Tingting Xia, Shujun Su, Rong Wu, Miaorong Zhan, Xuchu Hu, Huaiqiu Huang · 2025
Read D-lactic acid inhibits Candida albicans associated with vulvovaginal candidiasis: in vitro and in vivo effects and underlying mechanisms by Tingting Xia, Shujun Su, Rong Wu, Miaorong Zhan, Xuchu Hu, Huaiqiu Huang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12882367.txt.
Description
Tingting Xia and five co-authors test a bacterial acid against a yeast that plagues women in a 2025 study. Candida albicans drives vulvovaginal candidiasis, a common and often returning ill, and drug resistance is thinning the standard cures. D-lactic acid, made by friendly vaginal bacteria, was a candidate shield with an unclear mode of attack.
In dishes the acid curbed the yeast's switch to thread form and its biofilm building, dose by dose. Film mass and living activity both fell hard. Stains showed the cell skin leaking, and gene reads mapped the pathways hit. In a mouse model of the ill, the acid eased the infection in step with the dish work. The authors offer it as a fresh antifungal lead.
Catalog record
| CREATOR | Tingting Xia, Shujun Su, Rong Wu, Miaorong Zhan, Xuchu Hu, Huaiqiu Huang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |